Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Healthtrust
Baxter
Julphar
AstraZeneca
US Army
Medtronic
Fuji
Colorcon
Farmers Insurance

Generated: January 18, 2018

DrugPatentWatch Database Preview

CANTIL Drug Profile

« Back to Dashboard

Which patents cover Cantil, and when can generic versions of Cantil launch?

Cantil is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in CANTIL is mepenzolate bromide. There is one drug master file entry for this compound. Additional details are available on the mepenzolate bromide profile page.
Summary for CANTIL
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 34
Patent Applications: 969
Drug Prices:see details
DailyMed Link:CANTIL at DailyMed
Drug patent expirations by year for CANTIL

US Patents and Regulatory Information for CANTIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us CANTIL mepenzolate bromide SOLUTION;ORAL 010679-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us CANTIL mepenzolate bromide TABLET;ORAL 010679-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Novartis
Baxter
Harvard Business School
Medtronic
Mallinckrodt
Moodys
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot